X
NOW AVAILABLE IN THE U.S.
Visit MIPLYFFA.com

Safety and Efficacy of KP1077 in a Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Patients with Idiopathic Hypersomnia